Global Anti-Fungal Drugs Market to Surge to USD 21.2 Billion by 2032 The global surge in fungal infections particularly in immunocompromised individuals such as cancer patients, transplant recipients, and the elderly is fuelling the demand for effective anti-fungal therapies. Improved diagnostics and a wave of innovation in drug development, including combination therapies, are further...